This fact sheet provides information about the use of the hormone oxytocin in the Uniject device to prevent postpartum hemorrhage. It summarizes the benefits of using this innovative solution and also provides a success story based on a pilot study conducted in Mali.
Corporate author(s): PATH, POPPHI
Published: April 2008
Region: Global
Available materials
English
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
See also:
For more information…
Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA